Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Women previously treated with vaginal CO2 laser will receive an additional treatment 6 months after cessation of previous laser treatment or a sham laser treatment. The efficacy and safety of the additional treatment will be assessed.
The following study is intended to evaluate the efficacy and safety of an additional laser treatment for women previously treated for gynecological indications with laser treatments. Women will be randomized to one of 2 groups: 1. Study group-additional single laser treatment. 2. Control group-single sham laser treatment. All women will fill out validated questionnaires regarding sexual function, urinary stress incontinence and satisfaction after treatment. All women will be followed for an additional 6 months to evaluate the length of effect.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Additional laser treatment | Experimental | Women receiving a single laser treatment. |
|
| Sham laser treatment | Sham Comparator | Women receiving sham laser treatment. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CO2 laser | Device | A single session of CO2 vaginal laser treatment |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Length of effect | The duration of symptom improvement. | From the treatment session up to 6 months post-treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Female sexual function index | Changes in the female sexual function index questionnaire score (range 0-35) | From the treatment session up to 6 months post-treatment |
| Sexual intercourse | Improvement in the monthly rate of sexual intercourse |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Female
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Roy Lauterbach, MD | Rambam Health Care Campus | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rambam health care campus | Haifa | Israel |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D054020 | Lasers, Gas |
| ID | Term |
|---|---|
| D007834 | Lasers |
| D055096 | Optical Devices |
| D004864 | Equipment and Supplies |
| D055618 | Radiation Equipment and Supplies |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Sham laser |
| Device |
A single session of sham laser treatment. |
|
| From the treatment session up to 6 months post-treatment |
| Urinary distress index | Changes in the urinary distress index questionnaire score (range 0-15) | From the treatment session up to 6 months post-treatment |